FORUM ON DRUG DISCOVERY, DEVELOPMENT, AND TRANSLATION
FORUM ON DRUG DISCOVERY, DEVELOPMENT, AND TRANSLATION
批准号:
9091015
负责人:
Anne B Claiborne
金额:
$10.0万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-09-10 至 2020-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The Forum on Drug Discovery, Development, and Translation provides a unique platform for
dialogue and collaboration among thought leaders and stakeholders in government, academia,
industry, foundations, and patient advocacy with an interest in improving the system of drug
discovery, development, and translation. The Forum brings together leaders from private sector
sponsors of biomedical and clinical research, federal agencies sponsoring and regulating
biomedical and clinical research, the academic community, and patients, and in doing so serves
to educate the policy community about issues where science and policy intersect. The purpose is
to foster dialogue and discussion across sectors and institutions, and to illuminate issues, but not
necessarily resolve them. The Forum membership identifies topics that it wishes to address, and
with assistance from staff, develops public meetings, internal discussions, symposia, and
collaborations. The Forum does not provide advice or recommendations on any specific issue or
policy pending before any government agency; summary reports will result from the public
conferences.
The Forum convenes several times each year to identify, discuss, and act on key problems and
strategies in the discovery, development, and translation of drugs. To supplement the
perspectives and expertise of its members, the Forum also holds public workshops to focus
substantial public attention on critical areas of drug development. Summaries of these meetings
are disseminated to the public through printed reports and the Forum website. In addition to large
public workshops, Forum activities engage a wide range of experts, the policy community, and
members of the public in an informal setting. A combination of Forum members and outside
experts comprise several workgroups that examine high-priority issues in depth. In addition, the
Forum commissions or develops papers to undertake new research as well as synthesize existing
literature and explore scientific and policy issues on selected topics. The Forum also fosters
collaborations among its members and constituencies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceuticals: An IOM Workshop
-
批准号:8996009
-
项目类别:
-
资助金额:$4.99万
-
财政年份:2015
-
负责人:Anne B Claiborne
-
依托单位:
Strategies for the Responsible Sharing of Clinical Trial Data: Guiding Principles and a Framework for Implementation
-
批准号:8839023
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2014
-
负责人:Anne B Claiborne
-
依托单位:
FORUM ON DRUG DISCOVERY, DEVELOPMENT, AND TRANSLATION
-
批准号:8838373
-
项目类别:
-
资助金额:$9.98万
-
财政年份:2014
-
负责人:Anne B Claiborne
-
依托单位:
国内基金
海外基金
登录
查看更多内容
不同功能基团的电中性Drug-Free纳米颗粒的构建及克服肿瘤耐药的研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:杨胜彩
-
依托单位:
Drug-ADR-Pathway复合网络构建及ADR分子机制研究
-
批准号:61372188
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:陈秀杰
-
依托单位:
Drug-pHLA对接指纹图谱库的构建及HLA介导SADR的预测方法研究
-
批准号:61073135
-
项目类别:面上项目
-
资助金额:10.0万元
-
批准年份:2010
-
负责人:梅虎
-
依托单位:
新型药物传输系统drug-LDHs 复合纳米粒子的可控制备及其微结构对缓控释性能的调控
-
批准号:20776012
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2007
-
负责人:张慧
-
依托单位:
用Drug-Western法分离恶性疟原虫cDNA编码的青蒿素类药物结合蛋白
-
批准号:30070681
-
项目类别:面上项目
-
资助金额:14.0万元
-
批准年份:2000
-
负责人:程远国
-
依托单位: